A 21-year-old man with Still's disease with fever, rash, and pancytopenia

Arthritis Care and Research

Volumn 62, Issue 4, 2010, Pages 575-579

  Mehta, Bijal M ^a   Hashkes, Philip J ^a   Avery, Robin ^a   Deal, Chad L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEVER; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LEUKEMIA; LYMPHOMA; MACROPHAGE ACTIVATION; MALE; OPPORTUNISTIC INFECTION; PANCYTOPENIA; RASH; SEPSIS;

AMPHOTERICIN B; ANTIBODIES, MONOCLONAL; ANTIFUNGAL AGENTS; BONE MARROW EXAMINATION; HISTOPLASMOSIS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; STILL'S DISEASE, ADULT-ONSET; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77950427429     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20001     Document Type: Article

References (31)

1. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-430
2. Fautrel B, Zing E, Golmard JL, le Moel G, Bissery A, Rioux C, et al. Proposal for a new set of classification criteria for adult-onset Still's disease. Medicine (Baltimore) 2002;81:194-200. (Pubitemid 34507206)
3. Asrani NS. Disseminated histoplasmosis associated with the treatment of rheumatoid arthritis with anticytokine therapy [letter]. Ann Intern Med 2008;149:594-595
4. Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP. Fungal infections complicating tumor necrosis factor α blockade therapy. Mayo Clin Proc 2008;83:181-194
5. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006;295:2275-2285 (Pubitemid 43736578)
6. Sanchez A, Celaya AK, Victorio A. Histoplasmosis-associated hemophagocytic syndrome: a case report. AIDS Read 2007;17: 496-499 (Pubitemid 47599386)
7. Reiner AP, Spivak JL. Hematophagic histiocytosis: a report of 23 new patients and a review of the literature. Medicine (Baltimore) 1988;67:369-388
8. Pamuk ON, Pamuk GE, Usta U, Cakir N. Hemophagocytic syndrome in one patient with adult-onset Still's disease: presentation with febrile neutropenia. Clin Rheumatol 2007;26: 797-800.
9. Singh S, Samant R, Joshi VR. Adult onset Still's disease: a study of 14 cases. Clin Rheumatol 2008;27:35-39 (Pubitemid 350182675)
10. Janka GE. Hemophagocytic syndromes. Blood Rev 2007;21: 245-253
11. Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001;85:421-426 (Pubitemid 33702300)
12. Filipovich AH. Hemophagocytic lymphohistiocytosis and related disorders [review]. Curr Opin Allergy Clin Immunol 2006;6:410-415
13. De Jager W, Vastert SJ, Beekman JM, Wulffraat NM, Kuis W, Coffer PJ, et al. Defective phosphorylation of interleukin-18 receptor β causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2009;60:2782-2793
14. Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 2003;142:292-296 (Pubitemid 36338013)
15. Tsuda H, Shirono K. Possible role of macrophage-colony stimulating factor in the development of hemophagocytic syndrome [letter]. Eur J Haematol 1995;54:197.
16. Hadchouel M, Prieur AM, Griscelli C. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr 1985;106:561-566
17. Davies SV, Dean JD, Wardrop CA, Jones JH. Epstein-Barr virus-associated haemophagocytic syndrome in a patient with juvenile chronic arthritis. Br J Rheumatol 1994;33:495-497 (Pubitemid 24153978)
18. Stephan JL, Kone-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM. Reactive haemophagocytic syndrome in children with inflammatory disorders: a retrospective study of 24 patients. Rheumatology (Oxford) 2001;40:1285-1292 (Pubitemid 33100095)
19. Pringe A, Trail L, Ruperto N, Buoncompagni A, Loy A, Breda L, et al. Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication? Lupus 2007;16:587-592
20. Ravelli A, Caria MC, Buratti S, Malattia C, Temporini F, Martini A. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol 2001;28:865-867 (Pubitemid 32246959)
21. Stern A, Riley R, Buckley L. Worsening of macrophage activation syndrome in a patient with adult onset Still's disease after initiation of etanercept therapy. J Clin Rheumatol 2001; 7:252-256 (Pubitemid 32772086)
22. Grom AA. Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? [review]. Arthritis Rheum 2004;50:689-698
23. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 2002;14:548-552
24. Ravelli A, Magni-Manzoni S, Pistorio A, Besana C, Foti T, Ruperto N, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 2005;146:598-604. (Pubitemid 40616243)
25. Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor α-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum 2007;56:965-971 (Pubitemid 46399444)
26. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-131
27. Prahalad S, Bove KE, Dickens D, Lovell DJ, Grom AA. Etanercept in the treatment of macrophage activation syndrome. J Rheumatol 2001;28:2120-2124 (Pubitemid 32803794)
28. Ramanan AV, Schneider R. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis. J Rheumatol 2003;30: 401-403 (Pubitemid 36152611)
29. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005;201:1479-1486 (Pubitemid 40664091)
30. Kelly A, Ramanan AV. A case of macrophage activation syndrome successfully treated with anakinra. Nat Clin Pract Rheumatol 2008;4:615-620
31. Zeft A, Hollister R, LaFleur B, Sampath P, Soep J, McNally B, et al. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience. J Clin Rheumatol 2009;15:161-164